Prior to becoming Director of the Canadian Cancer Trials Group in 2014, Dr. Janet Dancey was Director, Translational Research – Clinical at Canadian Cancer Trials Group. She is also Scientific Director of the Canadian Cancer Clinical Trials Network and Director of the High Impact Clinical Trials Program at the Ontario Institute for Cancer Research. She is also Professor in the Department of Oncology at Queen's University.
Dr. Dancey has special expertise in new anti-cancer drug development, linking drug and biomarker development, and associated clinical trials methodology.
Prior to joining the Canadian Cancer Trials Group, Dr. Dancey was Senior Clinical Investigator in the Cancer Therapy Evaluation Program at the US National Cancer Institute and then Associate Chief of the Investigational Drug Branch. Dr. Dancey received her M.D. from the University of Ottawa and completed her residency training in internal medicine and medical oncology at the University of Toronto. In 1994-95, she was a research fellow with the Canadian Cancer Trials Group and continued her fellowship training at the Institut Gustave Roussy in France.
Let's spread the word about Immunotherapy! Click to share this page with your community.